share_log

ProKidney Shares Were Trading Higher After the Company Announced the Publication of the Trial Design and Early Data Analysis From REGEN-003 in the Journal of Blood Purification.

ProKidney Shares Were Trading Higher After the Company Announced the Publication of the Trial Design and Early Data Analysis From REGEN-003 in the Journal of Blood Purification.

在公司宣布在《血液淨化雜誌》上發布 REGEN-003 的試驗設計和早期數據分析之後,ProRin 股票的交易價格走高。
Benzinga Real-time News ·  2023/01/11 12:28

ProKidney shares were trading higher after the company announced the publication of the trial design and early data analysis from REGEN-003 in the Journal of Blood Purification.

在該公司宣布在《血液淨化雜誌》上發布 REGEN-003 的試驗設計和早期數據分析之後,ProRin 股票的交易價格走高。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論